Position
Fidelity in Intellia Therapeutics, Inc.
Back to the book · All holders of NTLA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $8.48M$12.82 → $16.92
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.76M | $15.8M | — | — | — | 0.0% |
| Q1 2026 | 2.07M | $26.5M | $12.82 | $6.74M | $3.94M | 0.0% |
| Q2 2026 | 4.77M | $80.8M | $16.92 | $8.48M | $45.8M | 0.0% |